当前位置: X-MOL 学术Am. J. Ophthalmol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Silk-Derived Protein-4 Versus Vehicle Control in Treating Patients With Moderate to Severe Dry Eye Disease: A Randomized Clinical Trial
American Journal of Ophthalmology ( IF 4.1 ) Pub Date : 2024-08-31 , DOI: 10.1016/j.ajo.2024.08.034
Brian D Lawrence 1 , Paul M Karpecki 2 , David W Infanger 1 , Brian Levy 3
Affiliation  

In this study the safety and efficacy of silk-derived protein 4 (SDP-4), also known as amlisimod, eye drops against a vehicle control formulation in patients with moderate to severe dry eye disease (DED) was assessed. SDP-4 is a novel, naturally derived, anti-inflammatory wetting agent that enhances coating on the ocular surface.

中文翻译:


蚕丝来源的蛋白 4 与载体控制治疗中度至重度干眼症患者:一项随机临床试验



在这项研究中,评估了蚕丝衍生蛋白 4 (SDP-4),也称为氨柳莫德,滴眼液对中度至重度干眼症 (DED) 患者载体对照制剂的安全性和有效性。SDP-4 是一种新型的天然衍生抗炎润湿剂,可增强眼表涂层。
更新日期:2024-08-31
down
wechat
bug